This synopsis reviews recent developments in dermatological phototherapy. UVA1
phototherapy (340-400 nm) is effective in the treatment of inflammatory skin diseases such …

Extracorporeal photopheresis (ECP) is a technique that was developed> 20 years ago to
treat erythrodermic cutaneous T‐cell lymphoma (CTCL). The technique involves removal of …

Extracorporeal photophoresis (ECP), a therapeutic modality that has been under
investigation for some years, is based on separation of a leucocyte/lymphocyte-enriched cell …

Extracorporeal photopheresis (ECP) is a leukapheresis-based therapy that uses 8-
methoxypsoralen and ultraviolet A irradiation. Used alone or in combination with biological …

Background After the first investigational study on the use of extracorporeal photopheresis
for the treatment of cutaneous T‐cell lymphoma was published in 1983 with its subsequent …

Extracorporeal photochemotherapy (extracorporeal photopheresis, ECP) is going to become
a new alternative in the treatment of cutaneous T cell lymphomas (CTCL), autoimmune …

Photopheresis or extracorporeal photochemotherapy (ECP) is a novel immunomodulatory
therapy which involves separation of the patient's leucocyte‐rich plasma, followed by ex vivo …

Three types of phototherapy and 2 forms of photochemotherapy are now available for
treatment of more than 40 diseases of the skin. Broadband ultraviolet B (UVB) phototherapy …

Despite the development of highly effective biologics for skin diseases such as psoriasis or
atopic dermatitis, UVA and UVB therapy, alone or in combination, are still essential …

Extracorporeal photopheresis (ECP) using UVA irradiation of enriched lymphocytes in the
presence of 8-methoxypsoralen as a photoactivatable substrate was originally introduced as …